Type 1 Diabetes (T1D): Clinical Trials

8 trials for Type 1 Diabetes (T1D), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 2 completed, 1 not yet recruiting. 8 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Recruiting 5, Completed 2, Not yet recruiting 1
Phase 11Recruiting 1

Follow Type 1 Diabetes (T1D): new trials by email Literature Review of Type 1 Diabetes (T1D) trials Research Report on Type 1 Diabetes (T1D)

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
Cadisegliatin 800 mg QD, Placebo - Type 1 Diabetes (T1D)
Phase 2RecruitingvTv Therapeutics402026-09-292026-11-10
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
AMX0035, Placebo - Type 1 Diabetes (T1D), Metabolic Diseases
Phase 2RecruitingUniversity of Washington602026-09-012026-09-15
Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo
Golimumab, Placebo (matching golimumab) - Type 1 Diabetes (T1D)
Phase 2Not yet recruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2552026-08-082026-07-06
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
CIR-0602K, Placebo - Type 1 Diabetes (T1D), Glycemic Control for Diabetes Mellitus
Phase 2RecruitingUniversity of Virginia402026-02-222026-02-25
Faecal Autologous Capsule Transplantation for Type 1 Diabetes Mellitus
freezedried autologous encapsulated fecal microbiota transplantation, placebo matching capsule without microbial content - Type 1 Diabetes Mellitis, Type 1 Diabetes (T1D)
Phase 2RecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1102025-09-012025-07-24
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
OPF-310 - Diabetes Mellitus, Type 1, Hypoglycemia
Phase 1 / Phase 2RecruitingOtsuka Pharmaceutical Factory, Inc.132025-06-102026-08-21
Lactobacillus Johnsonii Supplementation in Adults With T1D
L. johnsonii Probiotic, Placebo Capsule - Type 1 Diabetes (T1D)
Phase 2CompletedUniversity of Florida462020-02-012026-05-18
Lactobacillus Johnsonii in Children and Adolescents With T1D
L. johnsonii Probiotic, Placebo Capsule - Type 1 Diabetes (T1D)
Phase 2CompletedUniversity of Florida302019-10-102026-05-06

Narrower conditions

Diabetes Mellitus, Type 1 (8)  ·  Autoimmune Diseases (2)  ·  Glucose Metabolism Disorders (2)  ·  Immune System Diseases (2)  ·  Metabolic Diseases (2)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Hypoglycemia (1)  ·  Insulin Resistance (1)  ·  Ketosis (1)  ·  Nutritional and Metabolic Diseases (1)

Broader conditions

Diabetes Mellitus (7)  ·  Endocrine System Diseases (7)  ·  Nutritional and Metabolic Diseases (7)  ·  Autoimmune Diseases (6)  ·  Glucose Metabolism Disorders (6)  ·  Immune System Diseases (6)  ·  Metabolic Diseases (6)  ·  Acid-Base Imbalance (1)  ·  Acidosis (1)  ·  Hyperinsulinism (1)

Interventions

Sodium Chloride (1)  ·  TTP399 (1)  ·  golimumab (1)  ·  sodium phenylbutyrate and taurursodiol (1)

Sponsors

University of Florida (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Otsuka Pharmaceutical Factory, Inc. (1)  ·  University of Virginia (1)  ·  University of Washington (1)  ·  vTv Therapeutics (1)

Countries

United States (7)  ·  Netherlands (2)

Top investigators

Michael Haller (2)  ·  Jason Gaglia, MD (1)  ·  Maria Alba, MD (1)  ·  Petter M Bjornstad, MD (1)  ·  William B. Horton, MD (1)

NIH funding

R01DK121130 (1)